Amsterdam - Delayed Quote EUR
Pharming Group N.V. (PHARM.AS)
0.7450
+0.0090
+(1.22%)
At close: April 25 at 5:35:13 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-1,795
-1,795
-17,302
22,458
37,842
Investing Cash Flow
31,618
31,618
-129,388
5,323
-21,305
Financing Cash Flow
-34,412
-34,412
-1,039
-4,982
-27,947
End Cash Position
54,944
54,944
61,741
207,342
191,924
Capital Expenditure
-796
-796
-1,464
-1,977
-16,716
Issuance of Capital Stock
1,605
--
--
2,281
4,718
Issuance of Debt
104,539
104,539
--
--
--
Repayment of Debt
-138,932
-138,932
-4,038
-3,311
-3,217
Free Cash Flow
-2,591
-2,591
-18,766
20,481
21,126
12/31/2021 - 6/16/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GLPG.AS Galapagos NV
23.40
+1.83%
BIOS.BR BioSenic S.A.
0.0013
0.00%
CYAD.BR Celyad Oncology SA
0.4810
+0.21%
OXUR.BR Oxurion NV
0.0799
-6.98%
GLPG Galapagos NV
26.86
+1.40%
ALEMS.BR European Medical Solutions
5.50
+13.39%
05Y.F Vivoryon Therapeutics N.V.
1.8120
-2.16%
PTP.DE Pentixapharm Holding AG N
2.9050
-0.17%
1167.HK JACOBIO-B
3.910
+0.26%
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%